Main Session
Sep
28
PQA 03 - PQA 03: Digital Health Innovation and Informatics, Patient Safety & Quality, and Radiation and Cancer Biology
2556 - Metabolic Profiling as a Predictor of Hematopoietic Adverse Events in Patients Receiving ¹77Lu-PSMA-617 Radioligand Therapy
Presenter(s)
Neil Mookerjee, MD - Thomas Jefferson University, Philadelphia, PA